Aerobic Exercise and Gut Health: New Research Shows Reduced Zonulin and Inflammation Original paper

What was studied?

This randomized controlled trial investigated the effects of an eight-week aerobic exercise training program on body composition, lipid profiles, organokines (leptin and irisin), inflammatory biomarkers (high-sensitivity C-reactive protein [hs-CRP] and interleukin-6 [IL-6]), and intestinal barrier permeability markers (zonulin and lipopolysaccharide-binding protein [LBP]) in overweight and obese women. The researchers specifically aimed to determine whether these effects differed between young premenopausal women and middle-aged postmenopausal women. The exercise intervention consisted of treadmill running for 50 minutes per session, four times per week, at an intensity corresponding to 65% of target heart rate (calculated using the Karvonen formula), maintained consistently throughout the eight-week period without progressive overload. The study design included four groups (n=8 each): young exercise (YE), young control (YC), middle-aged exercise (ME), and middle-aged control (MC), allowing for direct comparison of exercise effects across age groups while controlling for age-related physiological differences, particularly those associated with menopausal status.

Who was studied?

The study enrolled 32 overweight and obese women (BMI ≥23 kg/m²) who were recruited through community advertisements in South Korea. The participants were stratified into two age groups: 16 young premenopausal adults (aged 20-33 years) and 16 middle-aged postmenopausal adults (aged 50-64 years). All participants were healthy, non-smoking, free from cardiovascular or musculoskeletal disorders that could limit exercise participation, and physically capable of completing moderate-intensity aerobic exercise. None were taking medications or dietary supplements known to affect metabolism or inflammation. Exclusion criteria included diagnosed metabolic diseases other than overweight/obesity, participation in regular exercise programs, current medication or supplement use that could influence outcomes, and smoking. Sample size was determined using G*Power software (effect size=0.40, α=0.05, power=0.95), indicating eight participants per group were required. All 32 participants completed the eight-week intervention without dropout, achieving 100% adherence to the supervised exercise sessions. The study was approved by the Institutional Review Board of Yonsei University, and all participants provided written informed consent. This study’s focus on aerobic exercise and intestinal barrier function across different age groups of women provides valuable insights into exercise responses influenced by menopausal status.

Most important findings

The study demonstrated that eight weeks of aerobic exercise training produced significant improvements across multiple health parameters in both young and middle-aged overweight and obese women. The findings related to aerobic exercise and intestinal barrier function are particularly noteworthy, as this is one of the first studies to comprehensively examine exercise-induced changes in gut permeability biomarkers alongside traditional metabolic and inflammatory outcomes in this population.

Significant time × group interactions were observed for nearly all primary outcomes: weight (F=13.500, p<0.001, partial η²=0.591), BMI (F=24.593, p<0.001, partial η²=0.599), body fat mass (F=9.876, p<0.001, partial η²=0.514), lean body mass (F=76.494, p<0.001), VO₂max (F=93.272, p=0.001, partial η²=0.425), total cholesterol (F=6.956, p=0.001, partial η²=0.427), triglycerides (F=3.982, p=0.018, partial η²=0.321), LDL-C (F=5.537, p=0.004, partial η²=0.372), leptin (F=7.167, p=0.001, partial η²=0.534), hs-CRP (F=3.942, p=0.018, partial η²=0.297), IL-6 (F=3.744, p=0.022, partial η²=0.253), zonulin (F=9.222, p<0.001, partial η²=0.497), and LBP (F=7.630, p=0.001, partial η²=0.450). The large effect sizes (partial η² values) indicate substantial practical impact of the intervention.

The reductions in intestinal barrier markers are particularly clinically relevant. Zonulin, which regulates tight junctions between enterocytes, decreased by 0.65-0.79 ng/mL in exercise groups, while LBP, which binds to LPS to initiate pro-inflammatory signaling, decreased by 0.45-0.48 μg/mL. These magnitudes are comparable to differences reported between metabolically healthy and unhealthy obese populations, suggesting clinically meaningful improvement in gut barrier function. The correlation analyses at baseline revealed important interrelationships: leptin positively correlated with LBP (r=0.54, p=0.001) and IL-6 (r=0.33, p=0.048); zonulin correlated with TC (r=0.59, p<0.001), LDL-C (r=0.61, p<0.001), and irisin (r=0.51, p=0.002); and hs-CRP correlated with IL-6 (r=0.39, p=0.027). These associations underscore the interconnected nature of adiposity, inflammation, lipid metabolism, and intestinal barrier integrity.

Importantly, the beneficial effects of aerobic exercise and intestinal barrier function were consistent across both young and middle-aged groups, indicating that menopausal status does not attenuate exercise-induced improvements in gut permeability. Both exercise groups showed significant reductions in zonulin and LBP compared to baseline, with no significant changes in control groups. This suggests that aerobic exercise can effectively improve intestinal barrier integrity regardless of age-related hormonal changes in women.

Key implications

This study provides compelling evidence that aerobic exercise training improves intestinal barrier function in overweight and obese women, as reflected by significant reductions in circulating zonulin and LBP levels. For clinicians managing patients with obesity-related metabolic dysfunction, these findings suggest that prescribing moderate-intensity aerobic exercise (e.g., 50-minute treadmill sessions, four times weekly at 65% target heart rate) may confer benefits beyond traditional weight management and cardiometabolic improvements. The improvement in gut barrier integrity—indicated by reduced zonulin and LBP—has important clinical implications because intestinal permeability is increasingly recognized as a contributor to systemic inflammation, insulin resistance, and metabolic syndrome. By reducing endotoxemia and strengthening the gut barrier, aerobic exercise may help break the vicious cycle of obesity-induced inflammation and metabolic dysregulation.

The consistency of effects across both young premenopausal and middle-aged postmenopausal women is particularly noteworthy. This suggests that exercise interventions can be equally effective in improving aerobic exercise and intestinal barrier function regardless of menopausal status, addressing a common clinical concern about age-related declines in exercise responsiveness. For middle-aged women transitioning through menopause—a period associated with increased visceral adiposity, metabolic deterioration, and chronic inflammation—these findings support aerobic exercise as a non-pharmacological strategy to preserve metabolic health and gut integrity.

The correlation findings also have clinical relevance. The positive association between leptin and LBP suggests that reducing adiposity through exercise may simultaneously lower endotoxemia. Similarly, correlations between zonulin and lipid parameters indicate that improving gut barrier function may contribute to better lipid metabolism. These interconnected relationships support a holistic approach to obesity management that recognizes the gut as a therapeutic target.

Several limitations warrant consideration when interpreting these findings. The eight-week intervention, while sufficient to detect significant changes, may not capture long-term sustainability of effects; future studies should include follow-up assessments. The absence of dietary monitoring is a significant limitation, as diet strongly influences lipid profiles, inflammation, and gut permeability. Participants were instructed to maintain habitual diets, but without formal tracking, dietary confounding cannot be excluded. The sample size, while statistically powered, was relatively small (n=32), and the inclusion of only women limits generalizability to men. Body composition was assessed using bioelectrical impedance rather than gold-standard DEXA, and waist circumference—a key measure of central adiposity—was not measured. VO₂max was estimated using the Bruce Protocol rather than cardiopulmonary exercise testing, though procedures were standardized. Only two organokines (leptin and irisin) were analyzed, providing a limited view of the broader network of adipose- and muscle-derived signaling molecules. Finally, the absence of direct microbiome analysis means we cannot determine whether improved intestinal barrier function was accompanied by favorable shifts in gut microbial composition. Despite these limitations, the study’s randomized controlled design, comprehensive biomarker panel, and stratification by menopausal status provide robust evidence supporting aerobic exercise as an effective intervention for improving gut barrier function alongside metabolic health in overweight and obese women.